Media News

BEIJING, March 25, 2022 /PRNewswire/ -- Peng Liyuan, wife of Chinese President Xi Jinping and World Health Organization (WHO) goodwill ambassador for tuberculosis (TB) and HIV/AIDS, attended a video conference for World Tuberculosis Day 2022 on Thursday.   "In recent years, thanks to the hard work of the WHO and the joint efforts of the international community,...

BEIJING, March 25, 2022 /PRNewswire/ -- Peng Liyuan, wife of Chinese President Xi Jinping and World Health Organization (WHO) goodwill ambassador for Tuberculosis (TB) and HIV/AIDS, addressed the World Tuberculosis Day video conference on Thursday.   Global tuberculosis control has achieved remarkable results in recent years with the active promotion of the World Health Organization and the...

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, March 25, 2022 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on oncology and immunology, today reported full year 2021 annual results. During the reporting period, the...

HONG KONG, March 24, 2022 /PRNewswire/ -- China Life Insurance Company Limited (SSE: 601628, SEHK: 2628, NYSE: LFC) announces the audited consolidated results of the Company (China Life Insurance Company Limited and its subsidiaries) for the year ended 31 December 2021 (the "Reporting Period") prepared under the International Financial Reporting Standards today. Highlights As...

SYDNEY, March 24, 2022 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs in oncology, is pleased to announce that an investigator-initiated trial (IIT) will commence shortly in the US investigating 64Cu SAR-bisPSMA in prostate cancer (NCT05286840). We look forward to continuing to...

The collaboration leverages Insilico's end-to-end AI-driven Pharma.AI platform to discover novel small molecule drug candidates for multiple targets, along with EQRx's innovative business model to accelerate drug development and patient access to novel medicines at affordable prices NEW YORK, March 24, 2022 /PRNewswire/ -- Insilico Medicine ("Insilico"), a clinical stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced...

HONG KONG, March 24, 2022 /PRNewswire/ -- Amid the severity of the fifth wave of the COVID-19 pandemic, a startup nurtured by The Hong Kong Polytechnic University (PolyU), known as iMeddy, is providing a free video medical consultation service on its pioneering online healthcare platform to a quota of 3,000 COVID-19 patients. The service is supported by an aggregate...

BANGKOK, March 24, 2022 /PRNewswire/ -- Cervical cancer is the second most common cancer in Thai women age 30-60, after breast cancer, with 10,000 new cases per year, and claiming as many as 5,000 lives annually. Though curable if detected early, many women are afraid of getting tested due to the cost, and their fear of the Pap Smear...

PETALING JAYA, Malaysia, March 24, 2022 /PRNewswire/ -- VISTA Eye Specialist (VISTA), one of leading eye specialists in Malaysia established since 1999, has recently won the Golden Bull 2021 Outstanding SME Award to round off an eventful year.   Ms. Chloe Wong,Chief Marketing Officer of VISTA Eye Specialist receiving the Golden Bull Award， the fourth award of the year...

Huma acquires AstraZeneca's digital health platform AMAZE™ and AstraZeneca becomes a shareholder of Huma LONDON and NEW YORK, March 23, 2022 /PRNewswire/ -- Huma Therapeutics Limited, a global digital health technology company advancing digital-first care delivery and research to help people live longer, fuller lives, today announced a new partnership with AstraZeneca to scale...